Skip to main content
. 2022 Nov 28;12(5):2202118. doi: 10.1002/adhm.202202118

Figure 5.

Figure 5

HA/CD44 binding activates different signaling pathways that promote chemoresistance and inhibit the apoptosis of tumor cells.